Results 81 to 90 of about 124,514 (155)

Identification of Carbapenemase Enzymes in Clinical Isolates of Enterobacteriaceae Using Modified Hodge Test

مجله دانشکده پزشکی اصفهان, 2014
Background: Carbapenem antibiotics are a subtype of beta-lactam antibiotics, which can play an important role in the treatment of severe infections and multi-drug resistant bacteria.
Reza Kamali Kakhki, Fereshteh Shahcheraghi, Mohamad Mehdi Aslani, Mohammad Yousef Alikhani   +3 more
doaj  

Risk Factors for Mortality and Antimicrobial Regimens in Pediatric Intensive Care Unit Patients with Carbapenem-Resistant Enterobacteriaceae Infections: A Six-Year Retrospective Study. [PDF]

Infect Drug Resist, 2022
Liu P, Mai Y, Yuan W, Xie L, Ma W, Liu J, Xu L, Yang J, Wang P, Wang H.   +9 more
europepmc   +1 more source

Development and validation of a scoring system for predicting cancer patients at risk of extended-spectrum b-lactamase-producing Enterobacteriaceae infections. [PDF]

BMC Infect Dis, 2020
Martínez-Valencia AJ, Gómez Martínez BJ, Montañez Ayala AM, García K, Sánchez Pedraza R, Jiménez Cetina LP, Gómez Rincón JC, Cuervo Maldonado SI.   +7 more
europepmc   +1 more source

Evaluation of the INCREMENT-CPE, Pitt Bacteremia and qPitt Scores in Patients with Carbapenem-Resistant Enterobacteriaceae Infections Treated with Ceftazidime-Avibactam. [PDF]

Infect Dis Ther, 2020
Jorgensen SCJ, Trinh TD, Zasowski EJ, Lagnf AM, Bhatia S, Melvin SM, Simon SP, Rosenberg JR, Steed ME, Estrada SJ, Morrisette T, Davis SL, Rybak MJ.   +12 more
europepmc   +1 more source

Risk factors and treatment advances for carbapenem-resistant Enterobacteriaceae infections in the urinary tract. [PDF]

Front Cell Infect Microbiol
Zhang X, Miao S, Ji C, Hu W.
europepmc   +1 more source

The potential of the microbiome as a target for prevention and treatment of carbapenem-resistant Enterobacteriaceae infections. [PDF]

Front Cell Infect Microbiol
Zhang L, Xu T, Chen W, Chai Y, Wu Y, Du X.   +5 more
europepmc   +1 more source

Predicting carbapenem-resistant Enterobacteriaceae infections in pediatric liver transplant recipients. [PDF]

World J Pediatr
Wang YY, Wang WL, Sun Y, Zhang W, Zhang YT, Gao SL, Wu J, Shen Y, Zhu ZC, Bai XL, Zhang Q, Liang TB.   +11 more
europepmc   +1 more source

Risk Factors and Prognosis of Polymyxin- and Carbapenem-Resistant Enterobacteriaceae Infections: A Propensity-Matched Real-World Study. [PDF]

Microorganisms
Xu J, Liang M, Luo Y, Qu J.
europepmc   +1 more source

Efficacy, Safety, and Cost-Effectiveness Analysis of Ceftazidime-Avibactam versus Polymyxin B in the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: A Target Trial Emulation. [PDF]

Infect Dis Ther
Hu N, Xiao F, Chen Y, Gu Q, Liang P, Xu Y, Liu J, Liu Y, Li YC, Xu Y, Liu M, Chen D, Zhang H.   +12 more
europepmc   +1 more source

The Economic Impact of Carbapenem Resistant-Non Lactose Fermenter and Enterobacteriaceae Infections on Hospital Costs in Dr. Soetomo General Academic Hospital Surabaya, Indonesia. [PDF]

Antibiotics (Basel), 2022
Lashari Y, Rochmanti M, Purba AKR, Notobroto HB, Sarassari R, Kuntaman K.   +5 more
europepmc   +1 more source